Erasca Ownership | Who Owns Erasca?

Overview Forecast RevenueFinancials Chart Transcripts

Erasca Ownership Summary

Erasca is owned by 93.46% institutional investors, 12.40% insiders. Frazier life sciences management is the largest institutional shareholder, holding 7.45% of ERAS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.53% of its assets in Erasca shares.

ERAS Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Erasca	93.46%	12.40%	-5.86%
Sector	Healthcare Stocks	47.06%	8.01%	44.93%
Industry	Biotech Stocks	44.97%	7.82%	47.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Frazier life sciences management	16.22M	7.45%	$38.27M
Vr adviser	16.22M	7.45%	$38.27M
Blackrock	10.61M	7.02%	$25.04M
Vanguard group	10.35M	6.85%	$24.43M
Suvretta capital management	13.77M	6.32%	$32.49M
Arch venture management	11.06M	5.08%	$26.09M
Artal group	9.63M	4.42%	$22.73M
Janus henderson group	8.18M	3.75%	$19.34M
Silverarc capital management	7.82M	3.59%	$18.45M
T. rowe price investment management	7.37M	3.39%	$17.40M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Arch venture management	11.06M	9.81%	$26.09M
Silverarc capital management	7.82M	4.35%	$18.45M
5am venture management	5.41M	2.85%	$12.76M
Vr adviser	16.22M	2.44%	$38.27M
Edbi pte	888.89K	2.37%	$2.10M
Prosight management, lp	2.75M	1.94%	$6.49M
Sio capital management	2.87M	1.84%	$6.78M
Frazier life sciences management	16.22M	1.79%	$38.27M
Vivo capital	6.76M	1.47%	$15.95M
Suvretta capital management	13.77M	1.19%	$32.49M

Top Buyers

Holder	Shares	% Assets	Change
Frazier life sciences management	16.22M	1.79%	16.22M
Vr adviser	16.22M	2.44%	16.22M
Suvretta capital management	13.77M	1.19%	13.77M
Janus henderson group	8.18M	0.01%	8.18M
Silverarc capital management	7.82M	4.35%	7.59M

Top Sellers

Holder	Shares	% Assets	Change
Armistice capital	-	-	-6.17M
Balyasny asset management	-	-	-4.32M
Schroder investment management group	-	-	-1.93M
Cvi	-	-	-1.46M
Exoduspoint capital management, lp	-	-	-1.19M

New Positions

Holder	Shares	% Assets	Change	Value
Frazier life sciences management	16.22M	1.79%	16.22M	$38.27M
Vr adviser	16.22M	2.44%	16.22M	$38.27M
Suvretta capital management	13.77M	1.19%	13.77M	$32.49M
T. rowe price investment management	7.37M	0.01%	7.37M	$17.40M
Paradigm biocapital advisors lp	7.25M	0.65%	7.25M	$17.11M

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-18.00
Gps wealth strategies group	-350.00
Eversource wealth advisors	-610.00
Allworth financial lp	-1.25K
Metropolitan life insurance co/ny	-1.53K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2024	127	15.45%	203,567,433	180.08%	93	4.04%	90	87.50%	23	-47.73%
Mar 31, 2024	110	-7.56%	72,682,320	4.96%	48	2.26%	48	-30.43%	44	33.33%
Dec 31, 2023	119	8.18%	69,248,421	-2.85%	46	2.05%	69	21.05%	33	17.86%
Sep 30, 2023	110	-0.90%	71,280,157	-4.07%	47	1.93%	57	-1.72%	28	7.69%
Jun 30, 2023	111	-5.13%	74,308,108	-4.76%	49	1.82%	58	-23.68%	26	23.81%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	7.15M	2.53%	-768.36K
iShares Russell 2000 ETF	4.44M	1.57%	-9.98K
T. Rowe Price Small-Cap Value	4.20M	1.49%	1.46K
T. Rowe Price US Small-Cap Core Equity	3.64M	1.29%	3.64M
T. Rowe Price Small-Cap Stock	3.64M	1.29%	-
Vanguard Institutional Extnd Mkt Idx Tr	3.31M	1.17%	577.67K
T. Rowe Price U.S. SC Value Eq Tr-Z	2.64M	0.94%	540.74K
SPDR® S&P Biotech ETF	2.56M	0.91%	28.35K
T. Rowe Price U.S. SC Core Eq Tr-Z	1.78M	0.63%	1.78M
T. Rowe Price Instl Small-Cap Stock	1.78M	0.63%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
May 21, 2024	Casdin Alexander W.	-	Buy	$181.92K
Dec 06, 2023	Start Valerie Denise Harding	-	Buy	$18.48K
Dec 05, 2023	Lim Jonathan E	Chairman & CEO	Buy	$1.22M
Dec 06, 2023	Lim Jonathan E	Chairman & CEO	Buy	$478.42K
Dec 04, 2023	Casdin Alexander W.	-	Buy	$49.78K

Insider Transactions Trends

Date	Buy	Sell
2024 Q2	1	-
2024 Q1	-	-
2023 Q4	5	-
2023 Q2	2	-
2023 Q1	2	-

ERAS Ownership FAQ

Who Owns Erasca?

Erasca shareholders are primarily institutional investors at 93.46%, followed by 12.40% insiders and -5.86% retail investors. The average institutional ownership in Erasca's industry, Biotech Stocks , is 44.97%, which Erasca exceeds.

Who owns the most shares of Erasca?

Erasca’s largest shareholders are Frazier life sciences management (16.22M shares, 7.45%), Vr adviser (16.22M shares, 7.45%), and Blackrock (10.61M shares, 7.02%). Together, they hold 21.91% of Erasca’s total shares outstanding.

Does Blackrock own Erasca?

Yes, BlackRock owns 7.02% of Erasca, totaling 10.61M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 25.04M$. In the last quarter, BlackRock increased its holdings by 3.63M shares, a 52.00% change.

Who is Erasca’s biggest shareholder by percentage of total assets invested?

Arch venture management is Erasca’s biggest shareholder by percentage of total assets invested, with 9.81% of its assets in 11.06M Erasca shares, valued at 26.09M$.

Who is the top mutual fund holder of Erasca shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Erasca shares, with 2.53% of its total shares outstanding invested in 7.15M Erasca shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools